150 related articles for article (PubMed ID: 16364696)
1. Improved assay for R(-)-apomorphine with application to clinical pharmacokinetic studies in Parkinson's disease.
Ingram WM; Priston MJ; Sewell GJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):1-7. PubMed ID: 16364696
[TBL] [Abstract][Full Text] [Related]
2. Sensitive quantification of apomorphine in human plasma using a LC-ESI-MS-MS method.
Abe E; Alvarez JC
Ther Drug Monit; 2006 Jun; 28(3):407-12. PubMed ID: 16778727
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease.
van der Geest R; van Laar T; Kruger PP; Gubbens-Stibbe JM; Boddé HE; Roos RA; Danhof M
Clin Neuropharmacol; 1998; 21(3):159-68. PubMed ID: 9617507
[TBL] [Abstract][Full Text] [Related]
4. Novel liquid chromatographic assay for the low-level determination of apomorphine in plasma.
Priston MJ; Sewell GJ
J Chromatogr B Biomed Appl; 1996 May; 681(1):161-7. PubMed ID: 8798925
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic method for the determination of pioglitazone in human plasma using ultraviolet detection and its application to a pharmacokinetic study.
Sripalakit P; Neamhom P; Saraphanchotiwitthaya A
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 843(2):164-9. PubMed ID: 16815107
[TBL] [Abstract][Full Text] [Related]
6. Development of a sensitive and rapid liquid chromatography/tandem mass spectrometry method for the determination of apomorphine in canine plasma.
Yang B; Zhu JB; Deng CH; Duan GL
Rapid Commun Mass Spectrom; 2006; 20(12):1883-8. PubMed ID: 16715476
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantitation of rosuvastatin and gemfibrozil in human plasma by high-performance liquid chromatography and its application to a pharmacokinetic study.
Vittal S; Shitut NR; Kumar TR; Vinu MC; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Nov; 20(11):1252-9. PubMed ID: 16838266
[TBL] [Abstract][Full Text] [Related]
8. Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease.
van der Geest R; Kruger P; Gubbens-Stibbe JM; van Laar T; Bodde HE; Danhof M
J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):131-41. PubMed ID: 9449564
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic method for simple and rapid determination of linezolid in human plasma.
Boak LM; Li J; Nation RL; Rayner CR
Biomed Chromatogr; 2006 Aug; 20(8):782-6. PubMed ID: 16292746
[TBL] [Abstract][Full Text] [Related]
10. Determination of lefucoxib in rat plasma, urine, and feces by high-performance liquid chromatography with fluorescence detection: application in pharmacokinetic studies.
Bi X; Meng Z; Dou G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):199-205. PubMed ID: 17161982
[TBL] [Abstract][Full Text] [Related]
11. Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection.
Loregian A; Scarpa MC; Pagni S; Parisi SG; Palù G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):358-64. PubMed ID: 17574937
[TBL] [Abstract][Full Text] [Related]
12. Determination of mianserin in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-ESI/MS): application to a bioequivalence study in Chinese volunteers.
Xu P; Li HD; Chen BM; Ma N; Yan M; Zhu YG
J Pharm Biomed Anal; 2008 Aug; 47(4-5):994-9. PubMed ID: 18514457
[TBL] [Abstract][Full Text] [Related]
13. A validated high-performance liquid chromatographic method for the determination of moclobemide and its two metabolites in human plasma and application to pharmacokinetic studies.
Plenis A; Chmielewska A; Konieczna L; Lamparczyk H
Biomed Chromatogr; 2007 Sep; 21(9):958-66. PubMed ID: 17450597
[TBL] [Abstract][Full Text] [Related]
14. A simple and sensitive high-performance liquid chromatographic method for quantification of PXD101, a histone deacetylase inhibitor in human plasma.
Zhang N; Goh BC; Khoo YM; Yeo W; Lee HS
Ther Drug Monit; 2007 Apr; 29(2):231-5. PubMed ID: 17417079
[TBL] [Abstract][Full Text] [Related]
15. Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Zou JJ; Bian XJ; Ding L; Zhu YB; Fan HW; Xiao DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):151-7. PubMed ID: 18069077
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of apomorphine in Parkinson's disease: plasma and cerebrospinal fluid levels in relation to motor responses.
Hofstee DJ; Neef C; van Laar T; Jansen EN
Clin Neuropharmacol; 1994 Feb; 17(1):45-52. PubMed ID: 8149359
[TBL] [Abstract][Full Text] [Related]
17. Dose response and concentration response relationship of apomorphine in patients with Parkinson's disease and end-of-dose akinesia.
Harder S; Baas H; Demisch L; Simon E
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):355-62. PubMed ID: 9707348
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a high-performance liquid chromatographic method for determination of pinocembrin in rat plasma: application to pharmacokinetic study.
Yang Z; Liu R; Li X; Tian S; Liu Q; Du G
J Pharm Biomed Anal; 2009 Jul; 49(5):1277-81. PubMed ID: 19361943
[TBL] [Abstract][Full Text] [Related]
19. Development of a gas chromatographic/mass spectrometric method to quantify R(-)-apomorphine, R(-)-apocodeine and R(-)-norapomorphine in human plasma and urine.
Libert F; Coudoré F; Richard D; Durif F; Eschalier A
J Mass Spectrom; 2005 Dec; 40(12):1521-5. PubMed ID: 16285020
[TBL] [Abstract][Full Text] [Related]
20. Determination of caderofloxacin lactate in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies.
Liu L; Pang X; Zhang D; Xu X; Liu H; Liang Y; Xie L; Liu X
J Pharm Biomed Anal; 2007 Dec; 45(5):799-803. PubMed ID: 17768026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
